Wnt signaling: Modulating tumor-associated macrophages and related immunotherapeutic insights
Biochemical Pharmacology · 2024-05 · 223 · 116154
DOI: 10.1016/j.bcp.2024.116154 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biochemical Pharmacology, 2024-05. Verfasst von Yimeng Yuan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Receptors-Mediated Gene Regulation and Drug Discovery, School of Basic Medical Sciences and Department of Urinary Surgery, Huaihe H…. Hauptthemen laut MEDLINE: Wnt Signaling Pathway, Neoplasms. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 142 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Henan Province Natural Science Foundation, Henan University, Health Commission of Henan Province.
Abstract (Originalsprache)
Wnt signaling pathways are highly conserved cascades that mediate multiple biological processes through canonical or noncanonical pathways, from embryonic development to tissue maintenance, but they also contribute to the pathogenesis of numerous cancers. Recent studies have revealed that Wnt signaling pathways critically control the interplay between cancer cells and tumor-associated macrophages (TAMs) in the tumor microenvironment (TME) and potentially impact the efficacy of cancer immunotherapy. In this review, we summarize the evidence that Wnt signaling pathways boost the maturation and infiltration of macrophages for immune surveillance in the steady state but also polarize TAMs toward immunosuppressive M2-like phenotypes for immune escape in the TME. Both cancer cells and TAMs utilize Wnt signaling to transmit signals, and this interaction is crucial for the carcinogenesis and progression of common solid cancers, such as colorectal, gastric, hepatocellular, breast, thyroid, prostate, kidney, and lung cancers; osteosarcoma; and glioma. Specifically, compared with those in solid cancers, Wnt signaling pathways play a distinct role in the pathogenesis of leukemia. Efforts to develop Wnt-based drugs for cancer treatment are still ongoing, and some indeed enhance the anticancer immune response. We believe that the combination of Wnt signaling-based therapy with conventional or immune therapies is a promising therapeutic approach and can facilitate personalized treatment for most cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Key Laboratory of Receptors-Mediated Gene Regulation and Drug Discovery, School of Basic Medical Sciences and Department of Urinary Surgery, Huaihe Hospital, Henan University, Kaifeng, China.
- Key Laboratory of Receptors-Mediated Gene Regulation and Drug Discovery, School of Basic Medical Sciences and Department of Urinary Surgery, Huaihe Hospital, Henan University, Kaifeng, China; Henan Provincial Research C…
- Kaifeng 155 Hospital, China RongTong Medical Healthcare Group Co. Ltd., Kaifeng, China; Henan Provincial Research Center for the Prevention and Diagnosis of Prostate Diseases, Henan University, Kaifeng, China. Electroni…
Förderung
- Henan Province Natural Science Foundation
- Henan University
- Health Commission of Henan Province
- Department of Science and Technology of Henan Province
Zitieren
APA
Yuan, Y., Wu, D., Hou, Y., Zhang, Y., Tan, C., Nie, X., Zhao, Z., & Hou, J. (2024). Wnt signaling: Modulating tumor-associated macrophages and related immunotherapeutic insights. Biochemical Pharmacology, 223, 116154. https://doi.org/10.1016/j.bcp.2024.116154
Vancouver
Yuan Y, Wu D, Hou Y, Zhang Y, Tan C, Nie X, et al. Wnt signaling: Modulating tumor-associated macrophages and related immunotherapeutic insights. Biochemical Pharmacology. 2024;223:116154. doi:10.1016/j.bcp.2024.116154
BibTeX
@article{Yuan2024,
author = {Yuan, Yimeng and Wu, Dapeng and Hou, Yifan and Zhang, Yi and Tan, Cong and Nie, Xiaobo and Zhao, Zhenhua and Hou, Junqing},
title = {Wnt signaling: Modulating tumor-associated macrophages and related immunotherapeutic insights},
journal = {Biochemical Pharmacology},
year = {2024},
volume = {223},
pages = {116154},
doi = {10.1016/j.bcp.2024.116154}
}
EUVIMED